As we all know, carcinoembryonic antigen (CEA) is a tumor marker for colon cancer, breast cancer, ovarian cancer, and other cancers, which can provide reliable information for the early diagnosis and treatment of tumor patients [1–3]. This evidence concerns the gene CEACAM5 and neoplasm.